AEMD Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 geg. 2024 @ 23:00):

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States...

Stats
Šios dienos apimtis	1.06M
Vidutinė apimtis	561 150
Rinkos kapitalizacija	1.05M
EPS	$0 ( 2024-02-14 )
Kita pelno data	( $-1.180 ) 2024-06-26
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0800
ATR14	$0.00200 (0.48%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-16	Broenniman Edward G	Buy	32 894	Common Stock
2024-04-16	Rossetti Angela	Buy	32 894	Common Stock
2024-04-16	Shah Chetan	Buy	32 894	Common Stock
2024-04-16	Gikakis Nicolas	Buy	32 894	Common Stock
2024-03-29	Gikakis Nicolas	Sell	1 954	Common Stock

INSIDER POWER
77.12
Last 96 transactions
Buy: 2 829 634 \| Sell: 209 502

Tūris Koreliacija

Ilgas: -0.25 (neutral)

Trumpas: 0.96 (very strong)

Signal:(45.698) Expect same movement, but be aware

Aethlon Medical Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
HSDT	0.9
MRAM	0.896
LINK	0.893
CETX	0.888
ARAY	0.887
RMNI	0.885
INTC	0.88
XRAY	0.876
CVRX	0.873
III	0.872

10 Labiausiai neigiamai susiję koreliacijos
IGTA	-0.904
IESC	-0.904
LSAK	-0.903
REAX	-0.899
PRCT	-0.894
XFIN	-0.887
SGMA	-0.883
MSSA	-0.877
GGAL	-0.877
USLM	-0.873

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Aethlon Medical Inc Koreliacija - Valiuta/Žaliavos

0.00
( neutral )

0.33
( neutral )

0.00
( neutral )

-0.13
( neutral )

Aethlon Medical Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$574 245
Bruto pelnas:	$-4.44B (-773 707.70 %)
EPS:	$-69.72

FY	2023
Pajamos:	$574 245
Bruto pelnas:	$-4.44B (-773 707.70 %)
EPS:	$-69.72

FY	2022
Pajamos:	$294 165
Bruto pelnas:	$139 948 (47.57 %)
EPS:	$-7.06

FY	2021
Pajamos:	$659 104
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-0.650

Financial Reports:

No articles found.

Aethlon Medical Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Aethlon Medical Inc

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.